PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 9 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Steroidal glycosides from F. foetida were evaluated for cytotoxic activity against HL-60 human leukemia, A549 human lung adenocarcinoma, and HSC-2 and HSC-4 human oral squamous carcinoma cells [PMID:19801882]. Furcreastatin selectively decreased the viability of mutant p53-expressing mouse fibroblasts (ED50 of 4.0 micrograms/mL) compared to parental cell-lines (ED50 of 9.6 micrograms/mL) [PMID:10782286].
Evidence summary
PubMed sources
- 1.PMID: 32167647 (2020) — Identification, pathogenicity and histopathology of Colletotrichum sansevieriae causing anthracnose of Sansevieria trifasciata in Malaysia. · Journal of applied microbiology
- 2.PMID: 35406353 (2022) — Processing, Characterization of Furcraea foetida (FF) Fiber and Investigation of Physical/Mechanical Properties of FF/Epoxy Composite. · Polymers
- 3.PMID: 29254019 (2018) — Study on characterization of Furcraea foetida new natural fiber as composite reinforcement for lightweight applications. · Carbohydrate polymers
- 4.PMID: 33491145 (2021) — Evaluation of Furcraea foetida (L.)Haw. for phytoremediation of cadmium contaminated soils. · Environmental science and pollution research international
- 5.PMID: 19801882